Cellosaurus BEC2 (CVCL_RQ14)
| Cell line name | BEC2 |
|---|---|
| Synonyms | BEC-2 |
| Accession | CVCL_RQ14 |
| Resource Identification Initiative | To cite this cell line use: BEC2 (RRID:CVCL_RQ14) |
| Comments | Group: Patented cell line. Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10153. Characteristics: Was investigated under the name Mitumomab for the treatment of small cell lung carcinoma in combination with BCG vaccination. Monoclonal antibody isotype: IgG2b, kappa. Monoclonal antibody target: Anti-idiotypic against monoclonal antibody R24. |
| Species of origin | Mus musculus (Mouse) (NCBI Taxonomy: 10090) |
| Hierarchy | Parent: CVCL_2199 (Sp2/0-Ag14) |
| Category | Hybridoma |
| Publications | PubMed=2056117; DOI=10.1172/JCI115276; PMCID=PMC296019 Patent=US5529922 |
| Cross-references | |
| Encyclopedic resources | Wikidata; Q54795957 |
| Entry history | |
| Entry creation | 05-Mar-2018 |
| Last entry update | 14-Aug-2025 |
| Version number | 5 |